Clinical and demographic factors associated with early relapse in patients with schizophrenia: a naturalistic observation study

Simple item page
dc.authoridGundogmus, Ibrahim/0000-0002-1921-1495
dc.authoridUZUN, OZCAN/0000-0002-4244-6911
dc.contributor.authorGundogmus, Ibrahim
dc.contributor.authorAydin, Mikail Burak
dc.contributor.authorOz, Sefa
dc.contributor.authorTasci, Azize Beril
dc.contributor.authorUzun, Ozcan
dc.date.accessioned2025-01-21T16:36:35Z
dc.date.available2025-01-21T16:36:35Z
dc.date.issued2021
dc.departmentKırıkkale Üniversitesi
dc.description.abstractSchizophrenia is a chronic psychiatric disorder progressing in relapses. Identification of many factors that may potentially increase the risk of relapse will be an important step in preventing relapses. The aim of this study was to determine the rate of early relapse in patients with schizophrenia and possible risk factors related to early relapse. The sample of this prospective study with the naturalistic observation design consisted of 308 patients with schizophrenia. The cutoff value for early relapse was determined as 1 year. The mean age of participants was 37.38 +/- 12.28 years and 66.6% of them were male (n = 205). The early relapse rate was 38.3%. The age younger than 35 [hazard ratio (HR) = 2.313; 95% confidence interval (CI), 1.518-3.526; P < 0.001], use of psychoactive substance (HR = 2.200; 95% CI, 1.407-3.440; P = 0.001), previous attempt of suicide (HR = 1.565; 95% CI, 1.028-2.384; P = 0.037), bad adherence to treatment (HR = 3.102; 95% CI, 1.358-7.086; P = 0.007), long-acting injectables (LAIs) antipsychotics in the treatment (HR = 0.534; 95% CI, 0.351-0.812; P = 0.003), combination typical-atypical antipsychotics (HR = 0.326; 95% CI, 0.131-0.807; P = 0.015), number of episodes (HR = 1.088; 95% CI, 1.043-1.134), and the score on the Side Effect factor of the Clinical Global Impressions Scale (HR = 1.826; 95% CI, 1.357-2.458; P < 0.001) were identified as the independent predictors of early relapse. It is remarkable that treatment bad adherence, use of psychoactive substance, no LAIs antipsychotics included in the treatment, and the no presence of the combination of typical and atypical antipsychotics are alterable predictors of early relapse.
dc.identifier.doi10.1097/YIC.0000000000000377
dc.identifier.endpage295
dc.identifier.issn0268-1315
dc.identifier.issn1473-5857
dc.identifier.issue6
dc.identifier.pmid34417787
dc.identifier.startpage288
dc.identifier.urihttps://doi.org/10.1097/YIC.0000000000000377
dc.identifier.urihttps://hdl.handle.net/20.500.12587/24341
dc.identifier.volume36
dc.identifier.wosWOS:000703727100002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofInternational Clinical Psychopharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.subjectearly relapse; predictor; psychoactive substance; schizophrenia; treatment adherence
dc.titleClinical and demographic factors associated with early relapse in patients with schizophrenia: a naturalistic observation study
dc.typeArticle

Files

Collections

WOS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu

We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics.
To learn more, please read our privacy policy.

Customize